Skip to content

Comparing the Effects of Two Herbal Remedies on Reducing Liver Fat in Adults with Fatty Liver Disease

A Randomized Controlled Trial to Evaluate the Effect of Vidangadi Churna in Comparison with Pippalyadi Churna in Reducing Liver Fat Accumulation in Adults with Non Alcoholic Fatty Liver Disease (NAFLD) - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106017
Enrollment
54
Registered
2026-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

None listed

Sponsors

Dr Kavita Rambhau Bhagat
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients aged between 25 and 60 years, irrespective of sex, occupation, or economic status. 2.Radiological evidence of fatty infiltration of the liver confirmed by abdominal Ultrasonography (USG) or other imaging modalities such as Contrast-Enhanced Computed Tomography (CECT). 3.Presence of clinical signs and symptoms suggestive of NAFLD (Yakrut Roga) such as loss of appetite, pain in the right upper quadrant or epigastric region, and nausea.

Exclusion criteria

Exclusion criteria: 1.Patients with alcohol intake exceeding 20 mL per day (history of alcohol intake was taken separately from the patients and close relatives) 2.Patients with positive diagnostic markers for other liver diseases such as Viral Hepatitis, Autoimmune Hepatitis, Wilson s Disease, Hemochromatosis. 3.Patients currently dependent on steroids or analgesic medications, or those who have participated in any other clinical trial within the last 6 months. 4.Patients who have undergone major surgery within 2 weeks prior to the screening visit.

Design outcomes

Primary

MeasureTime frame
Reduction in hepatic fat accumulation as measured by ultrasonographic grading before and after the 90-day intervention in adults with Non-Alcoholic Fatty Liver Disease (NAFLD).Timepoint: The follow-up time points are on the 30th, 60th, and 90th days of the intervention.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactVd Archana Dachewar

Shri Ayurved Mahavidyalaya

dr.dachewar@gmail.com9822206312

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026